DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Information Disclosure Statement
The information disclosure statement (IDS) submitted on 12/19/2024 is being considered by the examiner.
Status of Claims
Claims 1-12 are currently pending and under examination.
Priority
The instant application (filed on 12/19/2024) is a non-provisional application filed under 35 USC 111(a). Acknowledgment is made of Applicant's claim for foreign priority based on KR 10-2024-0107753 (filed on 08/12/2024). A machine translation via Espacenet (https://worldwide.espacenet.com) of KR 20260023864 is used to interpret the application KR 10-2024-0107753 - see attached for copy of translation. Based on this, instant claims 1-12 are adequately supported in the foreign application to receive an effective filing date of 08/12/2024.
Claim Rejections - 35 USC § 101
35 U.S.C. 101 reads as follows:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.
Section 33(a) of the America Invents Act reads as follows:
Notwithstanding any other provision of law, no patent may issue on a claim directed to or encompassing a human organism.
Claims 1-12 are rejected under 35 U.S.C. 101 and section 33(a) of the America Invents Act as being directed to or encompassing a human organism. See also Animals - Patentability, 1077 Off. Gaz. Pat. Office 24 (April 21, 1987) (indicating that human organisms are excluded from the scope of patentable subject matter under 35 U.S.C. 101). Claims 1-12 contain limitations which claim the device and body region. In order to provide a distinction between the device and the human organism (body region), the claim could incorporate language equivalent to “configured to” with respect to the device.
The following recite the limitations that encompass a human organism:
• Claim 1: “direct contact with at least two areas of user's facial skin”
• Claim 2: “operate to perform eye stimulation treatment in four areas of the facial skin” and “operate to perform sleep stimulation treatment in two areas of the facial skin”
• Claim 4: “which are provided to be worn over user's ears” and “so as to secure the treatment device to user's head”
• Claim 6: “the treatment signal supplied to the electrodes arranged in the two areas under user’s eyes”
• Claim 8: “which are arranged horizontally apart from each other at a first interval on the forehead area of a user” and “which are arranged horizontally apart from each other at a second interval on an under-eye area of the user”
• Claim 9: “which comes in direct contact with the user's facial skin and is equipped with the electrodes for directly electrically stimulating the user's facial skin” and “contracts to allow the electrodes to adhere to a user’s face according to shape of the user's face”
• Claim 10: “to ensure close adhesion to the facial skin” and “to ensure a close fit to user's face shape”
• Claim 12: “so that the left and right deformation is freely performed according to the face shape and the electrodes adhere close to the facial skin”
The rejections may be overcome by amending the claim to be configured for use with a body region.
Claims 3, 5, 7, and 11 are rejected for being dependent on rejected claims.
Claim Objections
The following claims are objected to because of the identified informalities:
Claim 1: The “receive treatment signals transmitted according to electrical connection” should be “receive treatment signals transmitted according to the electrical connection”
Claim 1: “a substrate part for generating and controlling treatment waveform” should be “a substrate part for generating and controlling treatment waveforms”
Claim 5: “controls and transmits corresponding treatment signal waveform to the electrode module parts” should be “controls and transmits the corresponding treatment signal waveform to the electrode module parts”
Appropriate correction is required.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION —The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claim 1: The term “low frequency” in the preamble is indefinite because the range of what constitutes a low frequency is not universal and may change based on individual opinion.
Claim 1: The limitation “a control circuit capable of performing at least one of eye treatment and sleep treatment is inserted” is indefinite because it is unclear what the control circuit is being inserted into.
Claim 1: The term “face frame” appears to lack an antecedent basis as the limitation
“a substrate housing arranged in a forehead area on a rear surface of face frame” assumes the term has been previously introduced.
Claim 1: The limitation “capable of performing at least one of eye treatment and sleep treatment” is indefinite because it is not clear would be required of the apparatus to enable it to perform an eye treatment or sleep treatment.
Claims 2-3, 5-7, and 11-12 are directed to a product (an electrical stimulation apparatus) and to a process (use of the electrical stimulation apparatus), which renders the claim indefinite. MPEP 2173.05(p).II states:
A single claim which claims both an apparatus and the method steps of using the apparatus is indefinite under 35 U.S.C. 112(b) or pre-AIA 35 U.S.C. 112, second paragraph. See In re Katz Interactive Call Processing Patent Litigation, 639 F.3d 1303, 1318, 97 USPQ2d 1737, 1748-49 (Fed. Cir. 2011)
These rejections may be overcome by amending the claim to recite the apparatus configuration, rather than actual method steps.
• Claim 2 is directed to both a product and a process. Claim 2 is directed to the apparatus of claim 1 and also requires the limitation “operate to perform eye stimulation treatment in four areas of the facial skin when first treatment waveform selected for the eye treatment is supplied, and operate to perform sleep stimulation treatment in two areas of the facial skin when second treatment waveform selected for the sleep treatment is supplied,” which are method steps.
• Claim 3 is directed to both a product and a process. Claim 3 is directed to the apparatus of claim 1 and also requires the limitation “wherein the substrate part and the electrode module parts are detachably coupled by magnets, and the selected treatment waveform is transmitted through pogo pins during electric connection,” which are method steps.
• Claim 5 is directed to both a product and a process. Claim 5 is directed to the apparatus of claim 1 and also requires the limitation “wherein when at least one treatment method of the eye treatment or the sleep treatment is selected, the treatment signal control unit generates, controls and transmits corresponding treatment signal waveform to the electrode module parts, and performs control so that a channel linkage method of the electrodes to which the treatment signal is transmitted is changed according to the treatment method selection of the eye treatment or the sleep treatment,” which are method steps.
• Claim 6 is directed to both a product and a process. Claim 6 is directed to the apparatus of claim 5 and also requires the limitation “the treatment signal control unit performs control so that when the eye treatment is selected, the treatment signal supplied to the electrodes arranged in the four areas is channel-linked up and down through the electrodes but not channel-linked left and right” and “the treatment signal supplied to the electrodes arranged in the two areas under user’s eyes is channel-linked left and right through the electrodes but not channel-linked up and down,” which are method steps.
• Claim 7 is directed to both a product and a process. Claim 7 is directed to the apparatus of claim 5 and also requires the limitation “wherein the treatment signal control unit controls wavelength of at least two LEDs included in the substrate part so as to emit wavelengths that are helpful for sleep,” which is a method step.
• Claim 12 is directed to both a product and a process. Claim 12 is directed to the apparatus of claim 11 and also requires the limitation “a first tilt deformation of the electrode module parts in the left and right directions is freely adjusted in bending or tilting up to resistance of the close-fitting adjustment part, so that the left and right deformation is freely performed according to the face shape and the electrodes adhere close to the facial skin, and a second tilt deformation of the electrode module parts in the up and down directions is adjusted in bending or tilting relatively less than the first tilt deformation, so that the electrode module parts are prevented from bending when sliding down,” which is a method step.
Claim 3: The term “the selected treatment waveform” lacks an antecedent basis. The term “the electrode module parts” in claim 3 suddenly allows for a plurality of electrode module parts while only a single electrode module part is defined in claim 1.
Claim 5: The term “the electrode module parts” in claim 5 suddenly allows for a plurality of electrode module parts while only a single electrode module part is defined in claim 1.
Claim 6: The term “the four areas” lacks an antecedent basis. While the term is defined in claim 2, claim 6 does not depend on claim 2.
Claim 7: The limitation “so as to emit wavelengths that are helpful for sleep, when the sleep treatment is selected” is indefinite because it is not clear what wavelengths are required to be helpful as part of a sleep treatment.
Claim 8: The limitation “the electrode module part includes first and second electrode module parts […] and third and fourth electrode module parts” is indefinite because the electrode module part is composed on additional versions of itself. Electrode module parts could be referred to as sub-modules. If the intention is to have electrode module parts 1-4 be referred to as “electrode module parts,” an alternative name for the overall structure containing the four modules should be considered in claims 1 and 8.
Claim 9: The term “certain distance” is indefinite because the word certain implies a particular distance which is not provided in the claim language. Either defining the certain distance or removing “certain” would enhance the clarity of the claim.
Claim 10: The terms “close adhesion” and “close fit” are indefinite because the word close is subjective and its meaning can vary person-to-person. Either defining “close” further or removing “close” would enhance the clarity of the claim.
Claim 11: The terms “the downward direction,” “the horizonal direction”, and “the upward direction” are indefinite because the orientation of elements in the upper and lower electrode frames are not clear. For example, claim 8 establishes directionality relative to directions on the face. However, claim 11 does not provide a reference from which to assess horizontal, downward, and upward. Reading through Applicant’s disclosure, the Examiner interprets “downward” as facing towards the lower electrode frame, “upward” as facing toward the upper electrode frame, and “horizontal” as being placed along an axis perpendicular to the axis established by the upper and lower electrode connection. The clarity of the claim would benefit from establishing directionality relative to structural elements within the electrode module part.
As provided in the current claims language, “the downward direction,” “the horizonal direction”, and “the upward direction” all lack an antecedent basis as well.
The “central area” is indefinite because it is unclear to what the area is central. This term is currently interpreted as central to the axis between the upper and lower electrode frames.
The term “certain distance” is indefinite because the word certain implies a particular distance which is not provided in the claim language. Either defining the certain distance or removing “certain” would enhance the clarity of the claim.
Claim 12: The term “electrodes adhere close to the facial skin” is indefinite because the word close is subjective and its meaning can vary person-to-person. Either defining “close” further or removing “close” would enhance the clarity of the claim.
Claim 4 is rejected for being dependent on a rejected claim.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claims 1 and 8 are rejected under U.S.C 102(a)(1) and U.S.C 102(a)(2) as being anticipated by Warschewske (US 2015/0018927 A1).
Regarding Claim 1, Warschewske discloses a low frequency electrode treatment device ([0037]), comprising:
• a substrate housing arranged in a forehead area on a rear surface of face frame (Figs. 1 and 3 show different embodiments positioned over the forehead and a band mechanism to attach to the head) so that a substrate equipped with a control circuit ([0037] – control unit supplying signals for optical and electrical stimulation is connected to embedded electrodes) capable of performing at least one of eye treatment and sleep treatment is inserted (See 112(b) rejection – the device in Warschewske is attached to the face and could be used to influence eye or sleep treatment);
• a substrate part for generating and controlling treatment waveform (Fig. 2 – a base body as part of the overall device with multiple electrodes 10 for stimulation) for performing at least one of eye treatment and sleep treatment ([0037] – the controller is able to generate multiple signals; in absence of waveform requirements for the two treatment types, any assignment of treatment type would be considered an arbitrary distinction which could be fulfilled by switching between two settings); and
• an electrode module part (electrodes 10), which is detachably provided in a module type so as to be electrically connected to the control circuit of the substrate part and performs stimulation treatment by electrodes (Fig. 4, [0057-0063] – electrodes are in two separable parts where 14 is connected to 13 and 13 is attached to the base body part), wherein the electrodes come into direct contact with at least two areas of user's facial skin and receive treatment signals transmitted according to electrical connection ([0037] – stimulation provided through electrodes, Fig. 2 – four locations of electrodes 10 identified).
Regarding Claim 8, Warschewske anticipates the low frequency electrode treatment device according to Claim 1, as indicated hereinabove. Warschewske further discloses wherein
• the electrode module part includes first and second electrode module parts, which are arranged horizontally apart from each other at a first interval on the forehead area of a user (Fig. 2 – shows four electrodes positioned in quadrants, where two electrodes are horizontally aligned above the eyes on the forehead), and
• third and fourth electrode module parts, which are arranged horizontally apart from each other at a second interval on an under-eye area of the user (Fig. 2 – shows four electrodes positioned in quadrants, where two electrodes are horizontally aligned below the eyes).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claims 2 and 5-7 are rejected under U.S.C 103 as being unpatentable over Warschewske (US 2015/0018927 A1) in view of Rockley (US 2020/0171307 A1).
Regarding Claim 2, Warschewske anticipates the low frequency electrode treatment device according to Claim 1, as indicated hereinabove. Warschewske discloses four electrodes positioned in quadrants, where two electrodes are horizontally aligned above the eyes on the forehead (Fig. 2). However, Warschewske does not disclose wherein the electrodes of the electrode module parts operate to perform eye stimulation treatment in four areas of the facial skin when first treatment waveform selected for the eye treatment is supplied, and operate to perform sleep stimulation treatment in two areas of the facial skin when second treatment waveform selected for the sleep treatment is supplied.
Rockley, in the same field of endeavor of stimulation applied by an arrangement of electrodes on the face ([0066]), teaches a series of electrodes, where electrodes are paired with a stimulation and return electrode, positioned above and below the eye where any number of electrodes can stimulate to provide the desired therapy and current distribution to the tissue ([0066]). Note that the return electrode of the pair does not need to be a distant electrode and can be one of the electrodes arranged around the eyes ([0055] - “This interpulse stimulation may be delivered using selected pairs of the electrodes that are located on/around the eye, and may omit the use of the distant return electrode, thus focusing the stimulation on the naso-lacrimal region, rather than directing current and electrical field deeper into the eye structure itself”)
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to alter Warschewske’s mask with four electrodes distributed into facial quadrants by incorporating the ability to stimulate electrode pairs individually in Rockley. This would have been obvious because both Warschewske and Rockley discuss stimulating the face with arrangements of electrodes and Rockley provides a solution/improvement by a system to pass current between specific pairs and numbers of electrodes to produce a particular spatial and density distribution of current. Therefore, a person of ordinary skill in the art would be motivated to improve the system of Warschewske by incorporating the ability to stimulate electrode pairs individually in Rockley.
Regarding Claim 5, Warschewske anticipates the low frequency electrode treatment device according to Claim 1, as indicated hereinabove. Warschewske discloses a treatment signal control unit ([0037] – the controller is able to generate multiple signals), wherein when at least one treatment method of the eye treatment or the sleep treatment is selected ([0037] - multiple waveforms can be selected, the eye and sleep treatment are seen as arbitrary naming conventions for different waveforms), the treatment signal control unit generates, controls and transmits corresponding treatment signal waveform to the electrode module parts ([0037]).
Warschewske discloses four electrodes positioned in quadrants (Fig. 2). However, Warschewske does not disclose performs control so that a channel linkage method of the electrodes to which the treatment signal is transmitted is changed according to the treatment method selection of the eye treatment or the sleep treatment.
Rockley, in the same field of endeavor of stimulation applied by an arrangement of electrodes on the face ([0066]), teaches a series of electrodes, where electrodes are paired with a stimulation and return electrode, positioned above and below the eye where any number of electrodes can stimulate to provide the desired therapy and current distribution to the tissue ([0066]). Note that the return electrode of the pair does not need to be a distant electrode and can be one of the electrodes arranged around the eyes ([0055] - “This interpulse stimulation may be delivered using selected pairs of the electrodes that are located on/around the eye, and may omit the use of the distant return electrode, thus focusing the stimulation on the naso-lacrimal region, rather than directing current and electrical field deeper into the eye structure itself”)
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to alter Warschewske’s mask with four electrodes distributed into facial quadrants by incorporating the ability to stimulate electrode pairs individually in Rockley. This would have been obvious because both Warschewske and Rockley discuss stimulating the face with arrangements of electrodes and Rockley provides a solution/improvement by a system to pass current between specific pairs and numbers of electrodes to produce a particular spatial and density distribution of current. Therefore, a person of ordinary skill in the art would be motivated to improve the system of Warschewske by incorporating the ability to stimulate electrode pairs individually in Rockley.
Regarding Claim 6, the low frequency electrode treatment device is obvious over Warschewske in view of Rockley according to claim 5, as indicated hereinabove. Warschewske discloses the controller is able to generate multiple signals ([0037]) and four electrodes positioned in quadrants (Fig. 2). However, Warschewske does not disclose wherein the treatment signal control unit performs control so that when the eye treatment is selected, the treatment signal supplied to the electrodes arranged in the four areas is channel-linked up and down through the electrodes but not channel-linked left and right, and when the sleep treatment is selected, the treatment signal supplied to the electrodes arranged in the two areas under user’s eyes is channel-linked left and right through the electrodes but not channel-linked up and down.
As stated in claim 5, the proposed combination with Rockley yields a series of electrodes, where electrodes are paired with a stimulation and return electrode, positioned above and below the eye where any number of electrodes can stimulate to provide the desired therapy and current distribution to the tissue ([0066]). Note that the return electrode of the pair does not need to be a distant electrode and can be pairs of electrodes arranged around the eye ([0055]). Additionally, current traveling between paired electrodes may travel between different hemispheres of the face (left -> right or right -> left) based on the desired current distribution for therapy ([0059] – pairing between left and right eyepatches).
Regarding Claim 7, the low frequency electrode treatment device is obvious over Warschewske in view of Rockley according to claim 5, as indicated hereinabove. Warschewske further discloses wherein the treatment signal control unit controls wavelength of at least two LEDs included in the substrate part so as to emit wavelengths ([0050] – left and right eyes are illuminated by surface 8 as part of the base body, as seen in Fig. 2) that are helpful for sleep (See 112(b) rejection – the device in Warschewske is attached to the face and could be used to influence eye or sleep treatment), when the sleep treatment is selected (the sleep treatment selection could merely be selecting a waveform setting in Warschewske).
Claim 3 is rejected under U.S.C 103 as being unpatentable over Warschewske (US 2015/0018927 A1) in view of Jeffrey (US 2016/0346530 A1).
Regarding Claim 3, Warschewske anticipates the low frequency electrode treatment device according to Claim 1, as indicated hereinabove. Warschewske discloses a snap-in connector for fixing electrode part 14 to connection 13 embedded in the device frame ([0056-0060]). However, Warschewske does not disclose wherein the substrate part and the electrode module parts are detachably coupled by magnets, and the selected treatment waveform is transmitted through pogo pins during electric connection.
Jeffrey, in the same field of endeavor of a transdermal electrode capable of electrical stimulation when applied to the head ([0018]), teaches “the distal end of the TES cable neurostimulator may include a set of connectors (e.g., snap connectors, magnetic connectors, multi-pin connectors, concentric connectors, etc.) complimentary to the connectors on the electrode assembly” ([0133]), where pin connectors are further identified potentially as POGO connecters ([00168] – “electrical current from a controller or current delivery device (neurostimulator) may be delivered to the traces through one or more connectors or pins, for example pogo pins or conductive snaps, extending from the controller to the second surface or from the second surface to the controller, such that the pogo pins/snaps are electrically connected with the traces”).
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to have modified the snap-fit connector in Warschewske with the magnetic and POGO pin connection mechanisms in Jeffrey. Warschewske describes the use of a snap fit connector while Jeffrey suggests different attachment mechanisms such as snap, conductive snap, magnetic, pogo pin, and concentric connectors, where the magnetic connecter and POGO pin connections would be obvious to try. A person of ordinary skill in the art would have a reasonable expectation of successfully implementing the magnetic and POGO pin connection in Jeffrey within the apparatus of Warschewske.
Claim 4 is rejected under U.S.C 103 as being unpatentable over Warschewske (US 2015/0018927 A1) in view of Asada (JP 2021051214 A). Note a machine translation via Espacenet (https://worldwide.espacenet.com) is used to interpret the disclosure in Asada - see attached for copy of translation.
Regarding Claim 4, Warschewske anticipates the low frequency electrode treatment device according to Claim 1, as indicated hereinabove. Warschewske discloses different embodiments positioned over the forehead and a band mechanism to be held to the head (Fig. 1 and 3). However, Warschewske does not disclose comprising temple parts, which are provided to be worn over user's ears and have silicon parts protruding from end portion areas with air-filled silicone so as to secure the treatment device to user's head and provide a cushion-like feeling.
The eyeglass frame in Asada would be considered “reasonably pertinent” (see MPEP
2141.01(a)1) to the claimed invention because Asada teaches a frame with cushioned temples for holding a front frame section in front of the face. The need for comfortably positioning a device in front of the face would be shared between the stimulation device in the instant application and Asada. Asada teaches a cushion fixed to the temple region of an eyeglass frame as a shock absorbing material to reduce impact on the wearer (Fig. 1, [0031] – “The cushion portion 50 functions, for example, as a shock-absorbing member that reduces impact on the wearer, and as a ventilation member that improves breathability to the wearer's body. The cushion portion 50 extends linearly along direction D1 from, for example, the second portion 12d of the hinge 12. The cushion portion 50 comes into contact with, for
example, the temple or ear of the wearer of the eyewear 1”). The cushioning material is further described in a previous publication as “the cushioning material is fixed to the nose pads, temples, and front of the glasses. The cushioning material is in sheet form, and the material used is a silicone-based viscoelastic material” ([0004]) and as an example of a possible material for the nose pad cushion ([0024]). The cushion is further defined as highly breathable ([0035] – “The interior of the cushion portion 50 has a hollow structure in which multiple cavities defined by multiple linear members 51 are arranged in a row. In other words, the cushion portion 50 has a hollow structure in which multiple cavities are arranged side by side inside. Therefore, the cushion portion 50 ensures high breathability”).
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to alter Warschewske’s mask with four electrodes distributed into facial quadrants by incorporating the cushioned temple attachment mechanism in Asada. This would have been obvious because both Warschewske and Asada discuss attachment mechanisms for holding frames in front of the face and Asada provides a solution/improvement with a cushioned temple element to be attached over the ears in order to enhance use comfort. Therefore, a person of ordinary skill in the art would be motivated to improve the system of Warschewske by incorporating the cushioned temple attachment mechanism in Asada.
Claim 9 is rejected under U.S.C 103 as being unpatentable over Warschewske (US 2015/0018927 A1) in view of in view of Jeffrey (US 2016/0346530 A1) and Sullivan (US 20170165485 A1).
Regarding Claim 9, Warschewske anticipates the low frequency electrode treatment device according to Claim 8, as indicated hereinabove. Warschewske discloses wherein each of the plurality of electrode module parts includes:
• an electrode part (felt 16 or metal 17 contact surfaces), which comes in direct contact with the user's facial skin and is equipped with the electrodes for directly electrically stimulating the user's facial skin according to the selected treatment waveform (Fig. 4, [0057-0062] – the 16 or 17 components in contact with the patient’s skin);
• an upper electrode frame for supporting the electrode part (Fig. 4, [0057-0062] - second part 14 connecting first part 13 and contact portions 16 or 17);
• a lower electrode frame, which is arranged at a certain distance from the upper electrode frame (Fig. 4, [0057-0062] - first part 13 attached to the device frame and in contact with second part 14).
However, Warschewske does not disclose a lower electrode frame has magnetic pogo pins to be detachably attached by magnets; and a close-fitting adjustment part, which is interposed between the upper electrode frame and the lower electrode frame and contracts to allow the electrodes to adhere to a user’s face according to shape of the user's face.
Jeffrey, in the same field of endeavor of a transdermal electrode capable of electrical stimulation when applied to the head ([0018]), teaches “the distal end of the TES cable neurostimulator may include a set of connectors (e.g., snap connectors, magnetic connectors, multi-pin connectors, concentric connectors, etc.) complimentary to the connectors on the electrode assembly” ([0133]), where pin connectors are further identified potentially as POGO connecters ([00168] – “electrical current from a controller or current delivery device (neurostimulator) may be delivered to the traces through one or more connectors or pins, for example pogo pins or conductive snaps, extending from the controller to the second surface or from the second surface to the controller, such that the pogo pins/snaps are electrically connected with the traces”).
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to have modified the snap-fit connector in Warschewske with the magnetic and POGO pin connection mechanisms in Jeffrey. Warschewske describes the use of a snap fit connector while Jeffrey suggests different attachment mechanisms such as snap, conductive snap, magnetic, pogo pin, and concentric connectors, where the magnetic connecter and POGO pin connections would be obvious to try. A person of ordinary skill in the art would have a reasonable expectation of successfully implementing the magnetic and POGO pin connection in Jeffrey within the apparatus of Warschewske.
Sullivan, in the same field of endeavor of stimulation applied by an arrangement of electrodes on the head ([0008]), teaches electrode pins can include spring-loaded features which provide variable pressure to the head to optimize electrical contact with the skin surface (Fig. 5B, [0076]), where the pins are placed between the contact point with the skin and the connection to the device frame.
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to alter Warschewske’s mask with four electrodes distributed into facial quadrants by incorporating the spring-loaded pins in Sullivan. This would have been obvious because both Warschewske and Sullivan discuss stimulating the head surface with arrangements of electrodes and Sullivan provides a solution/improvement by using springs acting on the electrode contact surface to ensure optimal electrical contact with the skin. Therefore, a person of ordinary skill in the art would be motivated to improve the system of Warschewske by incorporating the spring-loaded pins in Sullivan.
Claim 10 is rejected under U.S.C 103 as being unpatentable over Warschewske (US 2015/0018927 A1) in view of Jeffrey (US 2016/0346530 A1), Sullivan (US 20170165485 A1), and Rockley (US 2020/0171307 A1).
Regarding Claim 10, the low frequency electrode treatment device is obvious over Warschewske in view of Jeffrey and Sullivan according to claim 9, as indicated hereinabove. Warschewske discloses electrodes in contact with the surface of the face (Fig. 4, [0057-0063] – electrodes are in two separable parts where 14 is connected to 13 and contact portion 17 and 13 is attached to the base body part). However, Warschewske does not disclose wherein the electrode part has a surface shape formed in a curved arc shape like a bow so as to ensure close adhesion to the facial skin, and the close-fitting adjustment part is adjustable in length differently or equally for each of the four electrode modules so as to ensure a close fit to user's face shape.
Rockley, in the same field of endeavor of stimulation applied by an arrangement of electrodes on the head ([0008]), teaches electrode contact areas in a circular, rectangular, or other particular shape, such as a butterfly shape (Fig. 4, [0044]). This butterfly shape would be considered “a surface shape formed in a curved arc shape like a bow” under a broad interpretation of the claim language.
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to have modified the metal contact portion of the electrodes in Warschewske with the butterfly shaped contact area in Rockley. Warschewske shows the use of a circular electrode profile while Rockley suggests different shapes such as circular, rectangular, and butterfly-shaped based on which shape provides optimal stimulation coverage. In this case, the butterfly shape would be obvious to try. A person of ordinary skill in the art would have a reasonable expectation of successfully implementing the butterfly shape electrode contact area in Rockley within the electrode of Warschewske.
As stated in claim 9, the proposed combination with Sullivan yields electrodes with a spring-loaded feature which provides variable pressure to the head to optimize electrical contact with the skin surface (Fig. 5B, [0076]). In this sense, the spring creates a variable length dependent on the contact pressure with the skin. The “differently or equally” claim language covers all combinations of different lengths and renders the claims as requiring only the adjustable part is present in the electrodes.
Claims 11-12 are rejected under U.S.C 103 as being unpatentable over Warschewske (US 2015/0018927 A1) in view of Jeffrey (US 2016/0346530 A1), Sullivan (US 20170165485 A1), Altshuler (US 20160360990 A1), and Yamashita (US 6,926,363 A1).
Regarding Claim 11, the low frequency electrode treatment device is obvious over Warschewske in view of Jeffrey and Sullivan according to claim 9, as indicated hereinabove. Warschewske discloses electrode part 13 is connected to the device frame and detachable from part 14 (Fig. 4, [0057-0062]). However, Warschewske does not disclose wherein the upper electrode frame includes:
• a first bending adjustment clamp part, which extends in the downward direction and has a first fitting space formed in a central area for fitting; and
• a second bending adjustment clamp part, which is arranged in the horizontal direction at a certain distance from the first bending adjustment clamp part and has a second fitting space formed in a central area for fitting, and the lower electrode frame includes:
• a first bending adjustment support part, which extends in the upward direction and is fitted into the first fitting space; and
• a second bending adjustment support part, which is arranged in the horizontal direction at a certain distance from the first bending adjustment support part and is fitted into the second fitting space.
Altshuler, in the same field of endeavor of stimulation applied by an arrangement of electrodes on the head ([0002]), teaches pivot locations to adjust the position of the electrode contact portion relative to the head contour (Fig. 4 – depicted as a hinge to allow movement in one direction, [0017] – “A left electrode supporting panel 110 and a right electrode supporting panel 111 are pivotally attached to the headset 100 at pivot locations 108 essentially at the first and second ends. This embodiment depicts the electrode supporting panels 110 and 111 as curved to conform to the shape of a human head/skull”). The hinge is interpreted as a first bending adjustment clamp where an element from the electrode contact portion 110 is linked to an opposing element from headband frame 112 to form a hinge. However, the structure of the hinge is not sufficiently described to discern whether two of such linkages are formed.
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to alter Warschewske’s mask with four electrodes distributed into facial quadrants by incorporating the hinge joint to reposition the electrode contact part in Altshuler. This would have been obvious because both Warschewske and Altshuler discuss stimulating the head with arrangements of electrodes and Rockley provides a solution/improvement with the hinge to adjust the electrode to better match the contour of the head along one axis. Therefore, a person of ordinary skill in the art would be motivated to improve the system of Warschewske by incorporating the hinge joint to reposition the electrode contact part in Altshuler.
The angle-adjustable hinge in Yamashita would be considered “reasonably pertinent” (see MPEP
2141.01(a)1) to the claimed invention because Yamashita teaches a type of pivoting joint allowing two hinges to pivot with respect to a single axis. Examples are provided with respect to adjusting furniture, but Yamashita’s design can be applied to a variety of applications with two oscillating members (Col 2, Lines 29-38). Yamashita teaches a first arm 1 having attachment portion 18 and a second arm 2 having attachment portion 19 (where attachment portions have a defined space) are linked to connect elements 15 and 16 (Figs. 1-2, Col 2, Lines 29-59). Fig. 1 displays two hinges horizontally aligned on opposite ends of the pivoting axis. The pivoting hinge effectively limits adjustment to one axis (Fig. 17, Col 2, Lines 41-49 and Col 6, Lines 20-34).
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Warschewske with a two hinge design in Yamashita. Altshuler describes the use a hinge to allow the contact portion of the electrode to be pivoted to match the contour of the head while Yamashita suggests a multiple hinge design could be used to similarly pivot along one axis, which would be obvious to try as using a set number of hinges along the pivot axis. A person of ordinary skill in the art would have a reasonable expectation of successfully implementing the two hinge design with the proposed combination of Warschewske.
Regarding Claim 12, the low frequency electrode treatment device is obvious over Warschewske in view of Jeffrey, Sullivan, Altshuler, and Yamashita according to claim 11, as indicated hereinabove. Warschewske discloses electrode part 13 is connected to the device frame and detachable from part 14 (Fig. 4, [0057-0062]). However, Warschewske does not disclose wherein with the fitting, a first tilt deformation of the electrode module parts in the left and right directions is freely adjusted in bending or tilting up to resistance of the close-fitting adjustment part, so that the left and right deformation is freely performed according to the face shape and the electrodes adhere close to the facial skin, and a second tilt deformation of the electrode module parts in the up and down directions is adjusted in bending or tilting relatively less than the first tilt deformation, so that the electrode module parts are prevented from bending when sliding down.
As stated in claim 11, the proposed combination with Altshuler yields pivot locations to adjust the position of the electrode contact portion relative to the head contour (Fig. 4 – depicted as a hinge to allow movement in one direction, [0017] – “A left electrode supporting panel 110 and a right electrode supporting panel 111 are pivotally attached to the headset 100 at pivot locations 108 essentially at the first and second ends. This embodiment depicts the electrode supporting panels 110 and 111 as curved to conform to the shape of a human head/skull”). The hinge is interpreted as a bending adjustment clamp where an element from the electrode contact portion 110 is linked to an opposing element from headband frame 112 to form a hinge. Altshuler shows an up-down pivot action in Fig. 4, but the pivoting electrode could merely be rotated 90 degrees to achieve a pivoting motion in the left-right direction operating under the same principles with matching the contour of the head.
Contact Information
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Examiner Benjamin Schmitt, whose telephone number is 703-756-1345. The examiner can normally be reached on Monday-Friday from 9:00 am to 5:00 pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached on 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/Benjamin A. Schmitt/
Examiner
Art Unit 3796
/William J Levicky/Primary Examiner, Art Unit 3796